Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Update Il y a 4 ans
Reference: NCT02169440

Woman and Man

  • | Country :
  • Portugal
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to investigate CYP2C9 inhibition by BIA 9-1067 through the assessment of its effect on the pharmacokinetics of S-warfarin, a substrate of CYP2C9.


Inclusion criteria

  • Parkinson's disease (PD)

Links